Log In
Print this Print this

AKR 202

  Manage Alerts
Collapse Summary General Information
Company Akron Molecules AG
DescriptionOral small molecule purinergic receptor modulator and enzyme inhibitor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat osteoarthritis (OA) pain in the knee
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today